comparison of glp 1 receptor agonists between GLP-1 RA and the GLP-1/GIP dual agonist Treatment with GLP-1 Receptor Agonists
Description
Winzeler B, da Conceio I, Refardt J, et al
In Europe, there is a significant yet controlled GLP-1 market based on health technology appraisals, which decide whether the product will be covered by the government according to lower drug prices compared to the United States
The letter also noted that individuals who experience changes in vision while taking the medication should contact their healthcare provider
For maximizing weight loss, dual agonists are better
Endocr Connect 2017;6:856-65.ArticlePubMedPMC 30
